AbbVie (ABBV) announced the U.S. Food and Drug Administration approval of Emblaveo (aztreonam and avibactam). This marks the first ...

Reference is made to the stock exchange notice 5 February 2025 regarding Scatec ASA's issuance of new green bonds. In ...

Coop Pank invites shareholders, investors, analysts and other stakeholders to join its investor webinar, scheduled on 13 February 2025 at 9 am ...

North Macedonia's central bank lowered its key interest rate for the fourth straight policy session, but rate-setters felt the need ...

The Japanese market is trading notably higher on Thursday, extending the gains in the previous two sessions, following the broadly ...

E-Therapeutics plc, a company integrating computational power and biological data to discover life-transforming RNAi medicines, announced today that it will present new preclinical data demonstrating ...

The Company announces that on 3 February 2025 it bought back 15,000 of its own shares, to be held as treasury shares, at an average price of 1328 pence per share. Further details are set out below: ...

The Australian stock market is trading sharply lower on Monday, snapping the three-session winning streak, following the broadly ...

Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 3 February 2025 – Euronext, the leading pan-European market infrastructure, today announces the decision of S&P to upgrade Euronext from ...

Euro area consumers' inflation expectations for the next 12 months increased for a third straight month in December, while ...

Samsung Electronics Co Ltd (SMSN.L, SSNNF.OB, SSNLF.OB) reported that its fourth quarter net income attributable to shareholders of ...

Oculis Holding AG (Nasdaq: OCS; XICE: OCS) ("Oculis” or the "Company”), a global biopharmaceutical company, has issued registered ordinary shares of the Company, each with a nominal value of CHF 0.01, ...